CRWD vs PG: Which Is the Better Buy?
Side-by-side comparison of CrowdStrike Holdings, Inc. and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-09.
CrowdStrike Holdings, Inc. · Technology
$191.12
+32.7% upside to fair value
Grade B
VS
The Procter & Gamble Company · Consumer Defensive
$150.38
+10.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
CRWD has more upside to fair value
(+32.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRWD |
PG |
| Current Price |
$191.12 |
$150.38 |
| Fair Value Estimate |
$253.64 |
$165.39 |
| Upside to Fair Value |
+32.7%
|
+10.0%
|
| Market Cap |
$194.6B |
$350.2B |
| Forward P/E |
-4023.6x
|
21.5x
|
| EV / EBITDA |
570.3x
|
15.1x
|
| Price / Sales |
38.2x
|
4.0x
|
| Price / FCF |
134.0x
|
23.3x
|
| Revenue Growth YoY |
+25.6%
|
+7.4%
|
| Gross Margin |
75.0%
|
50.3%
|
| Operating Margin |
-3.9%
|
23.2%
|
| Return on Equity |
-0.6%
|
31.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
0.75%
|
4.29%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
CrowdStrike Holdings, Inc. operates in the technology sector, specifically in software infrastructure, providing cybersecurity solutions. The business quality is medium due to its strong revenue growth of 25.6% in the most recent quarter and impressive earnings growth of 125.2% in the same period, indicating effective scaling and operational leverage. However, profitability metrics remain challen…
The Procter & Gamble Company is a leading global consumer defensive company specializing in household and personal products with a strong portfolio across fabric care, baby and family care, beauty, health care, and grooming. The business quality is high, supported by a durable competitive moat from strong brands, consistent earnings growth, and prudent capital allocation emphasizing dividends and…
Accumulation Zones
| Metric |
CRWD |
PG |
| Zone Low |
$190.23 |
$124.04 |
| Zone High |
$215.59 |
$140.58 |
| In Buy Zone? |
Yes
|
No
|